![Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9f70f2ea-c603-4fb4-9959-ca62b8738b90/gr1.jpg)
Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology
![Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis - European Urology Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/870b8bc0-fc65-4a64-9840-e4f0f949bbab/gr1_lrg.jpg)
Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis - European Urology
![Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations | Journal of Comparative Effectiveness Research Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/cms/10.2217/cer.14.82/asset/images/medium/figure2.gif)
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations | Journal of Comparative Effectiveness Research
![PDF) Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard PDF) Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard](https://www.researchgate.net/profile/Thomas-Lam-3/publication/320835013/figure/tbl1/AS:614121494036483@1523429382067/Comparison-of-results-of-combining-docetaxel-with-ADT-table-from-guidelines_Q320.jpg)
PDF) Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard
![Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320300533-gr1.jpg)